‘Global Bioactive Wound Care Market Worth $8,052m In 2021’ Says Visiongain Report

28 August 2018
Pharma

Visiongain’s new report Global Bioactive Wound Care Market Forecasts 2017-2027: Biological Wound Care, Moist Wound Care and Antimicrobial Wound Care indicates that the global bioactive wound care market will see $8,052m in spending in 2021.

The global bioactive wound care market is expected to grow at a CAGR of 8.7% in the first half of the forecast period and CAGR of 7.5% in the second half of the forecast period. The market is expected to grow at a CAGR of 8.0% from 2017 to 2027. The market is estimated at $4,825 million in 2016, $8,052 million in 2021, and $12,420 million in 2027.

The lead analyst of the report said: “The bioactive wound care market is set to experience considerable growth over the next decade. The main drivers for the growth include an increasingly aging population, rising prevalence of diabetes and obesity, and growing patient awareness. In the case of patients suffering from chronic wounds, wound care has become a necessity in order to reduce the risk to one’s life. The number of patients suffering from all forms of chronic wounds is increasing worldwide at around 8% per year. The rising incidence provides an avenue for substantial growth in the bioactive wound care market over the coming years.”
The 213-page report contains 100 tables and 103 figures that add visual analysis in order to explain the developing trends within the Global Bioactive Wound Care Market. Visiongain provides revenue forecasts for the period 2017-2027 as well as qualitative analyses for the leading segments of this market: Biological Wound Care, Moist Wound Care, and Antimicrobial Wound Care.

The 213-page report offers market forecasts for the US, Canada, Germany, UK, Spain, Italy, France, Russia, Poland, Japan, China, India, South Korea, Australia, New Zealand, Brazil, Mexico, Turkey, Saudi Arabia, Israel and South Africa. In addition, the report contains a dedicated leading companies’ chapter covering companies leading the field in the bioactive wound care market.

The report Global Bioactive Wound Care Market Forecasts 2017-2027: Biological Wound Care, Moist Wound Care and Antimicrobial Wound Care report will be of value to anyone who wants to better understand the bioactive wound care market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the bioactive wound care industry.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Oncology remains the largest disease area in the pharmaceutical business. The oncology market is dominated by big pharma companies and high price labels” says Visiongain report

Although price is still the most important competitive advantage for a biosimilar company, current discount rates are not enough to automatically convince the key stakeholders of a biosimilar’s value.

10 September 2019

Read

“Anti-Infective Agents market set to grow to $141bn by 2024” says new Visiongain report

The global anti-infective agents market is one that is driven by innovation. This is vital for maintaining the rich pipeline of anti-infective agents seen in the market today.

09 September 2019

Read

“Global thyroid gland disorder treatment market is anticipated to grow at a lucrative CAGR of 3.6% and anticipated to reach USD 3.21 Billion by 2029”, says Visiongain report.

Thyroid disease is one of today’s most prevalent hormonal illnesses. Hyperthyroidism, hypothyroidism, and thyroid nodules are the most common thyroid gland disorders.

05 September 2019

Read

“Global somatostatin analogs market is anticipated to grow at a lucrative CAGR of 5.3% and anticipated to reach USD 4.78 Bn by 2029”, says Visiongain report.

Somatostatin was used to diagnose gastrointestinal tract tumors and acromegaly in the clinical environment.

05 September 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever